Oncobit
Oncobit is dedicated to improving cancer treatment through innovative and highly precise solutions for cancer monitoring. Their mission is to enable personalized cancer therapies by developing cancer-specific monitoring tests using advanced technologies, providing clinicians with accurate, reliable, and timely data to support therapy decisions. Their goal is to ensure patients receive the best possible treatment with optimal cost efficiency.
Industries
Nr. of Employees
small (1-50)
Products
Data-driven ctDNA cancer monitoring platform
A platform combining targeted ctDNA assays (reagents/kits) and cloud-based analysis software to provide sensitive, quantitative detection of cancer markers from blood and automated clinician reports.
Data-driven ctDNA cancer monitoring platform
A platform combining targeted ctDNA assays (reagents/kits) and cloud-based analysis software to provide sensitive, quantitative detection of cancer markers from blood and automated clinician reports.
Services
Provision of ctDNA testing services to clinical centers for patient monitoring and generation of clinical data to inform treatment decisions.
Collaborative services for clinical studies, including assay deployment and analysis to evaluate ctDNA as a pharmacodynamic or response biomarker.
Provision of ctDNA testing services to clinical centers for patient monitoring and generation of clinical data to inform treatment decisions.
Collaborative services for clinical studies, including assay deployment and analysis to evaluate ctDNA as a pharmacodynamic or response biomarker.
Expertise Areas
- Liquid biopsy and ctDNA-based molecular diagnostics
- Digital PCR assay development
- Targeted mutation hotspot detection for oncology
- Clinical biomarker implementation and monitoring
Key Technologies
- Digital PCR
- Circulating tumor DNA (ctDNA) analysis
- Targeted mutation hotspot detection
- Cloud-based analytics pipelines